Generative AI (GenAI) faces skepticism due to high-profile failures, prompting some organizations to limit or ban its use. Despite its risks, industries like pharmaceuticals and legal adopt GenAI for precision and time efficiency. In sales, GenAI enables faster insights, enhances prospect quality, and improves meeting documentation, presenting a competitive edge. Opportunity risk arises when companies forgo GenAI, leading to potential revenue losses. Examples of such risk include revenue loss in pharmaceutical research labs due to missed innovation opportunities.
Organizations that ignore Generative AI may face significant opportunity risks including loss of revenue, particularly in high-stakes industries such as pharmaceutical research and legal.
Effective use of Generative AI tools can enhance sales teams by improving prospect quality and speeding up insight generation from large datasets, creating competitive advantages.
Collection
[
|
...
]